Navigation Links
TandemHeart Approved for Expanded Reimbursement
Date:7/12/2011

PITTSBURGH, July 12, 2011 /PRNewswire/ -- The TandemHeart circulatory support system has been granted expanded reimbursement coverage by NHIC, Corp., the Medicare Administrative Contractor (MAC) serving over 1.3 million beneficiaries and over 53,000 healthcare providers in the Northeast region of the United States.

"We are extremely pleased with the decision by NHIC to expand coverage of the TandemHeart system," said Kraig McEwen, President and CEO of CardiacAssist, Inc.  "Supported by the growing body of clinical evidence on the use of TandemHeart, the action taken by NHIC ensures that health care providers in the Northeast receive adequate reimbursement coverage when caring for critically ill patients.  We are also extremely grateful to the independent societies and physicians that worked with NHIC to ensure that patients have access to the best possible care."

Physicians have utilized the TandemHeart device to provide critical heart support to over 2,500 patients at more than 170 of the top cardiac centers in the United States.  The system is composed of a small centrifugal pump, a series of cannulae which connect the pump to the patient and an electro-mechanical controller.  Starting from a small incision in a patient's leg, cannulae are inserted into the blood vessels and up to the heart.  The TandemHeart pump is then activated, allowing damaged heart muscle to rest while augmenting the flow of blood to the patient's vital organs and the rest of the body.

NHIC's Local Coverage Determination (LCD) for Percutaneous Ventricular Assist Devices (L31518) became effective July 8, 2011, and provides coverage of TandemHeart as a primary treatment option for a wide range of indications.  It applies to Medicare beneficiaries throughout NHIC's jurisdiction, including those located in Maine, Massachusetts, New Hampshire, Rhode Island and Vermont.

About TandemHeart

The FDA-cleared TandemHe
'/>"/>

SOURCE CardiacAssist, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
2. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
3. Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
4. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
5. Newly Approved HIV Drug Shows Great Promise
6. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
7. Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
8. Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
9. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
(Date:9/2/2015)... , Sept. 2, 2015  Research and ... of the "An Introduction to the Medical ... conference to their offering. ... European medical device legislation. It will explain the ... of Notified Bodies, how to choose one and ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and ... the "New EU Pharmacovigilance Legislation (London, UK - ... The 15 new EU modules concerning Pharmacovigilance ... Pharmacovigilance is conducted in Europe . ... these modules and their requirements, examine how they overlap ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
... Tissue Oncology, Society held in Seattle, Washington demonstrates clinical ... single agent in patients with ... chemo-insensitive sarcomas, NEW YORK, Nov. ... preliminary data demonstrating the,tolerability and clinical activity of KRX-0401 (perifosine) in ...
... (ASX: PGL; Nasdaq: PGLA) today announced additional,data from the ... this,year. This data was presented at the 58th Annual ... Diseases in Boston, USA(1). As the Phase 2 ... data analysis described in this presentation was performed to,evaluate ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3
(Date:9/2/2015)... Newark, NJ (PRWEB) , ... September 02, 2015 , ... ... as Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) donated $11,000 to ... initial $5,000 donation to the foundation at the start of The Barclays, Horizon BCBSNJ ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Hydration ... allopathic medicine, opens its second location this week at 31542 S. Coast Hwy, ... feet of lounge space for patients to relax while receiving safe and effective ...
(Date:9/2/2015)... Appleton, WI (PRWEB) , ... September 02, 2015 ... ... Midwest, Cypress Benefit Administrators is taking action after seeing a significant ... The TPA’s Argus Claim Review division has found many cases of OON ASCs ...
(Date:9/2/2015)... KS (PRWEB) , ... September 02, 2015 , ... Amada ... its newest office in Kansas – its Johnson County location. Amada franchise ... healthcare. Mike has a registered nurse background and spent over 20 years in medical ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... imaging, content, records and case management solutions and services to both government and ... Image Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... ... market with the release of their new ReActive™ Court Surface. , ... Salt Lake City, Utah (PRWEB) February 7, 2010 -- ... primary advantage of the new system is its adherence to metric standards, while still utilizing ...
... translates to success on playing field, author says , FRIDAY. ... odds of becoming a professional athlete, a new study suggests. ... League (AFL) players and found that many were born in ... born in the later months. , The Australian school year ...
... ... offering plastic surgery in Phoenix . For women who are interested in enhancing the ... with breast implants. , ... AZ (Vocus) February 6, 2010 -- Over the course of his career, Dr. Steven Turkeltaub ...
... ... Possibilities And Cost Savings for the Funeral Home , ... Waunakee, WI (PRWEB) February 6, 2010 -- When you are saying ... At today’s funerals, you might hear the buzzword “personalization” but you might not be sure ...
... CHICAGO, Ill. (February 6, 2010) In a study to ... annual meeting, The Pregnancy Meeting , in Chicago, researchers will ... of intrauterine fetal death (IUFD), commonly known as stillbirth, in ... rare and affects only six to seven out of every ...
... ... their Creams N, Lotions Facebook page or followers of their Twitter handle, @100sheabutter. Five randomly ... , ... 5, 2010 -- Reforma Group is announcing a special Valentine,s Day giveaway to fans of ...
Cached Medicine News:Health News:SnapSports Releases ReActive Court Surfacing For The International Sports Market 2Health News:Kids Born Early in Year More Likely to Be Athletes? 2Health News:Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures 2Health News:Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures 3Health News:Frazer Consultants Riding the New Wave in Funeral Home Stationery 2Health News:Study finds higher risk of stillbirth in women with fibroids 2Health News:Romantic Valentine's Day Gift Ideas: Keep Your Skin Soft & Naughty Gift Basket Giveaway 2
Coat-A-Count PAP IRMA,is an immunoradiometric assay designed,for the quantitative measurement of,prostatic acid phosphatase (PAP) in,serum. It is intended strictly for in vitro,diagnostic u...
For in vitro diagnostic use,with the IMMULITE 2000 Analyzer for,the quantitative measurement of prostatic,acid phosphatase (PAP) in serum, as an,aid in patient management....
Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
Medicine Products: